Impact Factor 4.259 | CiteScore 4.30
More on impact ›

Original Research ARTICLE

Front. Microbiol., 19 March 2020 | https://doi.org/10.3389/fmicb.2020.00424

Antimicrobial and Antivirulence Action of Eugenia brejoensis Essential Oil in vitro and in vivo Invertebrate Models

  • 1Biochemistry Department, Federal University of Pernambuco, Recife, Brazil
  • 2Biochemistry Department, Federal University of São Paulo, São Paulo, Brazil
  • 3Programa de Pós-graduação em Biologia Microbiana, CEUMA University, São Luís, Brazil
  • 4Department of Biology, University of Copenhagen, Copenhagen, Denmark
  • 5Department of Bacteria, Parasites and Fungi, Staten Serum Institut, Copenhagen, Denmark
  • 6Department of Science and Environment, Roskilde University, Roskilde, Denmark

Eugenia brejoensis L. (Myrtaceae) is an endemic plant from caatinga ecosystem (brazilian semi-arid) which have an E. brejoensis essential oil (EbEO) with reported antimicrobial activity. In this work, in vitro and in vivo models were used to characterize the inhibitory effects of EbEO in relation to Staphylococcus aureus. EbEO inhibited the growth of all tested S. aureus strains (including multidrug resistance isolates) with values ranging from 8 to 516 μg/mL. EbEO also synergistically increased the action of ampicillim, chloramphenicol, and kanamycin. The treatment with subinhibitory concentrations (Sub-MIC) of EbEO decreased S. aureus hemolytic activity and its ability to survive in human blood. EbEO strongly reduced the levels of staphyloxanthin (STX), an effect related to increased susceptibility of S. aureus to hydrogen peroxide. The efficacy of EbEO against S. aureus was further demonstrated using Caenorhabditis elegans and Galleria mellonella. EbEO increased the lifespan of both organisms infected by S. aureus, reducing the bacterial load. In addition, EbEO reduced the severity of S. aureus infection in G. mellonella, as shown by lower levels of melanin production in those larvae. In summary, our data suggest that EbEO is a potential source of lead molecules for development of new therapeutic alternatives against S. aureus.

Introduction

Staphylococcus aureus is the etiologic agent of a wide spectrum of clinical conditions ranging from superficial skin infections and soft tissue infections to severe sepsis (Asgeirsson et al., 2018; Mcneil and Fritz, 2019; Turner et al., 2019). The indiscriminate use of antibiotic has induced the emergence of multidrug resistant (MDR) strains that have spread from hospital settings to different environmental and victimized various individuals (Mcneil and Fritz, 2019; Turner et al., 2019).

Indeed, both hospital- and community-associated S. aureus strains display complex combinations of virulence and resistance genes and have been related to increased ratios of morbidly and mortality and represent serious concerns for global systems worldwide (De Carvalho et al., 2019; Liang et al., 2019; Vestergaard et al., 2019). The major drugs currently used against methicillin-resistant S. aureus (MRSA) are vancomycin, teicoplanin, linezolid, and daptomycin (Werth et al., 2014); however, isolates with resistance or low susceptibility have been detected for all these drugs (Endimiani et al., 2011; Kos et al., 2012; Capone et al., 2016; Bakthavatchalam et al., 2017). Taken together, these data justify the search for new alternatives for the treatment of infections caused by S. aureus, and plant-derived products are highlighted as interesting candidates (Dos Santos et al., 2016; Mittal et al., 2018).

Plants are known to produce a large variety of molecules with interest for pharmaceutic and food industries, among them are the volatile compounds present in the essential oils (EOs) (Alves et al., 2017; Mittal et al., 2018; Stevanovic et al., 2018; Taghavi et al., 2018; Rao et al., 2019). EOs are complex mixture of secondary metabolites produced by aromatic plants usually involved in their protection against pathogens (Mittal et al., 2018). Several EOs have been demonstrated as efficient antimicrobial agents able to inhibit different MDR strains and to improve the activity of antibiotics (Langeveld et al., 2014; Mittal et al., 2018; Rao et al., 2019). The EOs components can interact with multiple targets in bacteria such as membrane, proteins synthesis, as well as inhibit efflux pumps and virulence related pathways (such as biofilm formation and toxin production) (Dos Santos et al., 2016; Kim et al., 2016; Kong et al., 2016b; Kang et al., 2018; Mittal et al., 2018; Rubini et al., 2018; Espinoza et al., 2019).

Eugenia brejoensis is an EO-bearing plant from Mytaceae family which has been described as an endemic species in Brazil (present in the states of Pernambuco, Sergipe, Alagoas, Paraíba, Espirito Santo) (Mazine and Souza, 2008; Giaretta and Peixoto, 2014; Mendes et al., 2018). The E. brejoensis EO (EbEO) is mainly composed by sesquiterpenes (such as δ-cadinene, β-caryophyllene, and α-muurolol) (Da Silva et al., 2015). EbEO has shown inhibitory actions against Aedes aegypti larvae (Da Silva et al., 2015) and Trypanosoma cruzi (Oliveira De Souza et al., 2017). In relation to antibacterial activity, nanoemulsions of EbEO were able to inhibit the growth of Pseudomonas fluorescens (Mendes et al., 2018). The present work aims to demonstrate the efficacy of EbEO against S. aureus using in vitro and in vivo invertebrate models (Caenorhabditis elegans and Galleria mellonella).

Materials and Methods

Plant Material

Leaves of E. brejoensis were collected at Parque Nacional do Catimbau (Pernambuco, Brazil) on dry season (September, 2015). All the plant material was processed following the usual techniques in taxonomy and deposited in the Herbarium of Instituto Agronomico de Pernambuco (voucher access number: IPA 84.033). The EO was obtained from leaves of E. brejoensis (EbEO) by hydrodistillation as previously reported (Da Silva et al., 2015). The oil used in this study was characterized by gas chromatography–mass spectrometry (GC/MS) and the chemical profile was published by Da Silva et al. (2015).

Bacterial Strains Used in the Study

The standard strain S. aureus ATCC 29312 was used in most of the assays. The antimicrobial activity of EbEO was further analyzed against a collection of clinical isolates of S. aureus deposited in the Microbial Collection of Departamento de Antibioticos from Universidade Federal de Pernambuco (UFPEDA). The antibiotic resistance profile of each strain is shown in Table 1. The strains used in the present study are part of Dr. Anders Løbner-Olesen collection at University of Copenhagen. The expression of virulence- and SOS-related genes (hla, spa, or recA) was performed using strains carrying the targeted genes fused with lacZ (which encodes for β-galactosidase) (Nielsen et al., 2010; Gottschalk et al., 2013). The strains in Table 1 were kindly shared by Prof. Hanne Ingmer, Copenhagen University.

TABLE 1
www.frontiersin.org

Table 1. Antimicrobial effects of EbEO in association to antibiotics.

Determination of Minimum Inhibitory Concentration

The antimicrobial activity of EbEO was determined against the standard strains S. aureus ATCC 29312 and clinical isolates (Table 1). Serial dilutions (1024 to 2 μg/mL) of EbEO were prepared in 96-wells plates containing Luria–Bertani (LB) broth. Each well received 10 μL of a microbial suspension [bacterial load of approximately 1.0 × 107 colony forming units per milliliter (CFU/mL) for each well]. The plates were incubated at 37°C, and after 24 h each well received 30 μL of 0.03% resazurin sodium solution (Sigma–Aldrich®). Following, the plates were incubated for 40 min and the minimum inhibitory concentration (MIC) was defined as the lowest concentration capable of inhibiting bacterial growth (as evaluated color change).

Time-Kill Studies

Overnight cultures of S. aureus ATCC 29312 were diluted 1:100 in LB broth and placed in a shaking water bath at 37°C until an optical density at 600 nm (OD600) of 0.1 was reached. This microbial suspension was distributed in fresh LB broth containing EbEO (128 or 1024 μg/mL; corresponding to 2 × MIC or 8 × MIC, higher concentrations was applied to verify action of concentrations greater than MIC50). Bacteria treated with ciprofloxacin (2 μg/mL; 2 × MIC) or without treatment were used as positive and negative controls, respectively. Cell growth was monitored in specific time points (0, 1, 2, 3, 4, and 5 h) by plating 4 μL of 10-fold-diluted suspensions from each tube in quadruplicate. The plates were incubated at 37°C for 24 h. After this period, the colonies were counted for the calculation of CFU/mL.

Combinatory Effects

The interaction between EbEO and some important clinical used drugs (ampicillin—25 μg/mL, ciprofloxacin—0.78 μg/mL, chloramphenicol—12.5 μg/mL, erythromycin—0.39 μg/mL, and kanamycin—6.25 μg/mL) were evaluated using checkerboard assay against S. aureus ATCC 29312. Fractional inhibitory concentration index (FICI) was assessed algebraically using the following equation:

FICI=FICEbEO+FICD=(EbEO/MICEbEO)+(D/MICD)

Where “EbEO” is the concentration (μg/mL) of EbEO in a given well, and MICEbEO represents the control MIC of EbEO alone. “D” is the concentration of the tested drug in a given well, and MICD represents the MIC of the tested drug alone. The interactions were defined as: (i) synergistic if FICI ≤ 0.5; (ii) additive if 0.5 < FICI ≤ 1; (iii) non-interaction if 1 < FICI < 4; and (iv) antagonistic if FICI ≥ 4 (Da Silva et al., 2016).

Expression of Virulence- and SOS-Related Genes Through β-Galactosidase Activity

The effects of EbEO on the expression of genes related to virulence and SOS pathways were performed using S. aureus 8325-4 derivative strains carrying the targeted genes (hla, spa, or recA) fused with lacZ (which encodes for β-galactosidase) (Vestergaard et al., 2015). In all assays, each strain was exponentially grown in LB medium until an OD600 between 0.1 and 0.2. Cells were treated with EbEO (64 μg/mL, 0.5 × MIC), and permeabilizated by toluene (1 mL) after 3 h. The β-galactosidase activity was measured using ONPG (ortho-nitrophenyl-β-galactoside; Sigma–Aldrich). In the assays for recA expression, ciprofloxacin (0.5 μg/mL) was used as positive control.

Evaluation of Staphyloxanthin (STX) Inhibition

Overnight cultures of S. aureus ATCC 29312 were diluted (1:100) in LB medium and samples (1 mL) of this suspension were incubated with sub-inhibitory concentrations of EbEO (64, 32, and 16 μg/mL, corresponding, respectively, to 0.125 × MIC, 0.25 × MIC, and 0.5 × MIC). After overnight incubation at 37°C, the tubes were centrifuged (10,000 r/min for 10 min), suspended with 1 mL of phosphate-buffered saline (PBS), and re-centrifuged. Bacteria pellets were then photographed. Following the total carotenoid pigments [including staphyloxanthin (STX)] in each pellet were extracted using in methanol (0.2 mL) and incubated for 3 min at 55°C. The methanol phase (supernatant) and cell debris were separated by centrifugation (10,000 r/min for 10 min) and the pellets were submitted to entire pigment extraction procedure three more times. Finally, the absorbance was determined at 465 nm (Silva et al., 2017).

Effect of EbEO on Susceptibility of S. aureus to Hydrogen Peroxide

Microbial suspension (standardized at OD600 = 1.0; Liu et al., 2005) prepared from overnight cultures of S. aureus ATCC 29312 were incubated with sub-inhibitory concentrations of EbEO (64, 32, and 16 μg/mL, corresponding, respectively, to 0.125 × MIC, 0.25 × MIC, and 0.5 × MIC). Each culture received H2O2 to reach a final concentration of 1.5% (v/v) for 60 min and were incubated at 37°C. The percentage of cells surviving the stresses was calculated as CFU/mL remaining after each stress divided by the initial CFU/mL.

Anti-hemolytic Evaluation

Staphylococcus aureus ATCC 29312 overnight cultures were diluted at 1:100 in fresh LB and cultured with or without sub-inhibitory concentrations of EbEO (64 and 32 μg/mL) at 37°C. After 16 h (to guarantee a constant number of bacteria present in experiment), 50 μL of culture supernatant was added to 1 mL of 3% human erythrocytes solution. The mixture was incubated at 37°C for 1 h with 250 r/min shaking. The supernatant was collected by centrifugation at 10,000 r/min for 10 min, and the optical density was measured at 540 nm.

Bacterial Activity in Whole Blood

To verify whether EbEO could enhance the antimicrobial action in whole blood, the S. aureus ATCC 29312 (diluted in LB medium; 1:100) was grown in the presence of EbEO (64 and 32 μg/mL) at 37°C with shaking of 250 r/min. After 6 h, the S. aureus suspension (62.5 μL) with EbEO (64 or 32 μg/mL) were mixed with freshly drawn human whole blood (0.5 mL) and re-incubated in the conditions described above for 2 h. The samples were plated in LB agar and the survival was measured by counting viable colonies (expressed as CFU/mL) (Lee et al., 2013).

Infectious Model With Caenorhabditis elegans

The infection model was performance using C. elegans AU37, a temperature-sensitive sterile strain [sek-1(km4); glp-4(bn2) I; MAPK kinase deficiency] (Jakobsen et al., 2013). The strain was propagated on nematode growth medium (NGM) containing Escherichia coli OP50 as food source. Prior each assay, the worms were age-synchronized by bleaching with alkaline hypochlorite and sodium hydroxide. The released embryos were placed on NGM plates at 25°C (this temperature does not allow the reproduction) until reached the young adult stage. At this time, 15 larvae were transferred to 24-wells plates containing the M9 liquid medium and overnight culture S. aureus ATCC 29312 (grown in LB medium containing 10 μg/mL cholesterol) in a ratio of 4:1 (v/v) (Kong et al., 2014). EbEO (128, 64, and 32 μg/mL) was added and the worm longevity was assessed every day. OP 50 was used with positive control (worm and E. coli) and S. aureus was used with negative control (worm and ATCC 29312). The animals were classified as dead when they did not present spontaneous movement or response after stimulation with a platinum loop. All experiments were performed according to Wormbook (Stiernagle, 2006).

Infectious Model With Galleria mellonella

Galleria mellonella larvae (∼200 mg) were randomly distributed in three experimental groups (n = 10) with or without oil treatment. Two groups were infected by injection of 10 μL of a recent S. aureus ATCC 29312 suspension (1.0 × 105 CFU; different bacterial concentrations was previously optimized to guarantee an inicial sublethal load to this assay), into the last left proleg, followed by incubation at 37°C. After 2 h, one of these groups received 10 μL of 128 μg/mL EbEO (resulting in dose of 6.4 mg/kg). Larvae treated with PBS (vehicle) were used as positive control.

Quantification of S. aureus Load in G. mellonella Hemolymph

Galleria mellonella larvae were infected with S. aureus ATCC 29312 and treated with EbEO as described above. Each day, a total of five larvae were cut in the cephalocaudal direction with a scalpel blade and squeezed to remove the hemolymph. Each sample was 10-fold-diluted in PBS and 4 μL was plated on LB agar. After 24h-incubation at 37°C, the colonies were enumerated, and the results expressed as CFU/mL.

Quantification of Hemolymph Melanization

Melanization test concerns the production of this pigment under stress conditions. G. mellonella (n = 10) were infected with S. aureus ATCC 29312 (106 cells/larva) aimed to evaluate melanization as a response to higher concentrations of bacteria (stress) and to quantify this response as a function of the melanin/time correlation after being treated with 6.4 mg/kg EbEO. After the incubation (1 or 3 h), the hemolymph was collected and diluted (1:10; v/v) in cold PBS. The cells suspensions were centrifuged at 12,000 r/min and the absorbance of each supernatant was determined at 465 nm.

Statistical Analysis

All assays were performed in triplicate in at least two independent experiments. Statistical analyses were performed using the software GraphPad Prism version 7.1 Data were analyzed by one-way, two-way analysis of variance (ANOVA), and Tukey test. A p-value of < 0.05 was considered as statistically significant. Differences in the survival were determined using the Kaplan–Meier method and log-rank test was used to compare survival curves.

Results

EbEO Enhances the Activity of Drugs Toward S. aureus

Initially, we performed a microdilution-based assay to evaluate antimicrobial activity of EbEO against all tested S. aureus strains, including those with multidrug resistance profile (MDR strains). This oil inhibited the standard S. aureus ATCC 29312 with an MIC of 128 μg/mL, while the MIC values for the other strains ranged from 8 to 516 μg/mL. The MIC50 (concentration able to inhibit 50% of the tested strains) was 128 μg/mL (Table 1).

Following, a time-kill study was performed using EbEO at 128 μg/mL (2 × MIC) or 1024 μg/mL (8 × MIC). Both oil concentrations were able to inhibit the growth of S. aureus ATCC 29312 without any significant differences among them. After 3 h, the oil induced reductions of 50% in the number of viable colonies when compared to untreated cells. The oil exhibited a profile, similar to the observed from ciprofloxacin (0.5 μg/mL) (Figure 1). Further, the action of EbEO was not associated with an increased expression of recA, the first gene related with the activation of SOS response, a pathway involved in the DNA repair (Vestergaard et al., 2015) (Figure 2).

FIGURE 1
www.frontiersin.org

Figure 1. Effects of Eugenia brejoensis essential oil (EbEO) on growth of Staphylococcus aureus. S. aureus ATCC 29312 was treated with 2 × MIC (256 μg/mL) or 8 × MIC EbEO (1024 μg/mL). Bacteria treated with ciprofloxacin (CIP at 2 μg/mL; 2 × MIC) or without treatment were used as positive and negative controls, respectively. Samples were taken every hour to assess bacterial viability.

FIGURE 2
www.frontiersin.org

Figure 2. Effects of Eugenia brejoensis essential oil (EbEO) on expression of recA. The expression of recA was performed using a derivative S. aureus 8325-4 strain carrying a recA:lacZ fusion. Bacteria were treated with EbEO (64 μg/mL; 0.5 × MIC) or ciprofloxacin (CIP at 0.5 μg/mL; 0.5 × MIC) for 3 h. β-Galactosidase activity was measured using ONPG. * Indicates significant differences in relation to control cells (p < 0.05).

Next, we determined whether EbEO could improve the action of some antibiotics (from different classes) toward S. aureus. EBEO synergistically increased the action of ampicillin (ΣFIC: 0.45), chloramphenicol (ΣFIC: 0.15), and kanamycin (ΣFIC: 0.075), while it had additive effects with ciprofloxacin (ΣFIC: 0.6) and erythromycin (ΣFIC: 0.6).

EbEO Affects the Expression of Quorum Sensing-Related Genes of S. aureus and Its Hemolytic Activity

Following, we evaluated the effects of EbEO on the expression of two gene of this system (hla and spa that encode alpha-hemolysin and protein A, respectively). It is expected that a quorum sensing inhibitor (QSI) reduces the expression of hla and increases the transcriptional levels of spa (Nielsen et al., 2010). Based on this, the results indicated the EbEO (at 0.5 × MIC) could alter the expression of hla (downregulation) and spa (upregulation), suggesting that this oil is QSI (Figures 3A,B).

FIGURE 3
www.frontiersin.org

Figure 3. Influence of Eugenia brejoensis essential oil (EbEO) on some virulence properties of S. aureus. (A) Effects of EbEO on expression of hla using S. aureus 8325-4 derivative strains carrying hla:lacZ. (B) Effects of EbEO on expression of spa using S. aureus 8325-4 derivative strains carrying spa:lacZ. (C) Interference of EbEO on hemolytic activity of S. aureus. (D) Inhibition of EbEO on S. aureus survival on whole blood. * Indicates significant differences in relation to control cells (p < 0.05).

We further analyzed whether EbEO could decrease the hemolytic activity of S. aureus and its ability to survive in human blood. The treatment with EbEO (0.5 × MIC or 0.25 × MIC) strongly inhibited the hemolysis-mediated by S. aureus (around 90% of inhibition) (Figure 3C). Similarly, the survival of this pathogen on blood was impaired by subinhibitory concentrations (Sub-MIC) values of EbEO (Figure 3D).

EbEO Inhibits the Production of Staphyloxanthin and Increases the Susceptibility of S. aureus to Hydrogen Peroxide

Figure 4A shows that EbEO strongly reduced the levels of staphyloxanthin in a dose-dependent manner (95.63 ± 0.98 and 89.38 ± 1.49% for EbEO at 64 or 32 μg/mL, respectively). In addition, the treatment with EbEO (at 64 or 32 μg/mL; 0.5 × MIC or 0.25 × MIC) potentialized the toxicity of hydrogen peroxide (1.5% v/v) toward S. aureus (Figure 4B). Similar levels of viability reduction were observed for both concentrations (24.12 ± 4.19 and 20.87 ± 0.87% for EbEO at 64 and 32 μg/mL, respectively), when compared to cells treated with hydrogen peroxide alone (p < 0.05). These results suggest that the inhibition of staphyloxanthin production by EbEO impaired the antioxidant system of S. aureus and increased its susceptibility to oxidant attack. Based on these findings, we decided to evaluate the anti-infective efficacy of EbEO using two alternative experimental models: C. elegans and G. mellonella.

FIGURE 4
www.frontiersin.org

Figure 4. Eugenia brejoensis essential oil (EbEO) reduces the staphyloxanthin production and S. aureus resistance to hydrogen peroxide. (A) EbEO inhibits the staphyloxanthin production. (B) The survival of S. aureus after oxidative stress is reduced by EbEO. * Indicates significant differences in relation to control cells (p < 0.05). # Indicates significant differences in relation to H2O2 cells (p < 0.05).

EbEO Increases the Lifespan of C. elegans Infected by S. aureus

The infection of C. elegans by S. aureus resulted in a reduction of worm viability and 8 days post-infection (dpi) the survival ratio of this group was 30%, while the uninfected animals showed 90% survival at this day (Figure 5A). The median survival of S. aureus-infected worms was 7 days. This scenario was radically changed by the treatment with EbEO at 128 or 64 μg/mL. The animals treated with 128 μg/mL EbEO showed survival curve similar to control group (p > 0.05). In the end (8 dpi), the survival of worms treated with EbEO were around 60 and 80%, for concentrations of 64 or 128 μg/mL, respectively (Figure 5A). In addition, the C. elegans larvae treated with 128 μg/mL EbEO (MIC) also exhibited lower bacterial load than those incubated with 64 μg/mL EbEO (Figure 5B). It is important to highlight that the tested EbEO concentrations did not significantly reduce the viability of C. elegans when compared with PBS-treated group (data not shown).

FIGURE 5
www.frontiersin.org

Figure 5. Eugenia brejoensis essential oil (EbEO) protects Caenorhabditis elegans larvae from Staphylococcus aureus infection. (A) Effects of EbEO on Survival of C. elegans larvae infected with S. aureus. (B) Bacterial load. * Indicates significant differences in relation to control cells (p < 0.05).

EbEO Protects Galleria mellonella Larvae Against the S. aureus Infection

The antibacterial activity of EbEO was further analyzed using G. mellonella larvae. EbEO treatment did not show any toxicity to these larvae, resulting in survival curves similar to those observed to PBS-treated animals (data not shown). The larvae infected with S. aureus showed 100% mortality in the third day and this group exhibited a median survival of 1 day. On the other hand, the treatment with a single dose of EbEO (6.4 mg/kg) protected 70% of the larvae at the end of the experiment (4 dpi) (Figure 6A).

FIGURE 6
www.frontiersin.org

Figure 6. Effects of Eugenia brejoensis essential oil (EbEO) on Galleria mellonella infected with S. aureus. (A) EbEO improves the survival of G. mellonella infected with S. aureus. (B) EbEO reduces the load of S. aureus in hemolymph. (C) Effects of EbEO on melanin production after 1 h of S. aureus-infection. (D) Effects of EbEO on melanin production after 3 h of S. aureus-infection. * Indicates significant differences in relation to uninfected larvae (p < 0.05). # Indicates significant differences in relation to uninfected and S. aureus-infected larvae (p < 0.05).

Interestingly, EbEO treatment induced small effects on the bacterial load when compared to initial bacterial inoculum (time 0), suggesting a bacteriostatic action (Figure 6B). In relation to S. aureus-infected larvae, EbEO-treated animals exhibited significantly lower levels of bacteria in hemolymph in all days evaluated (around 3 log CFU/mL reductions for all days; p < 0.05).

Finally, we evaluated whether EbEO could reduce the overproduction of melanin induced by S. aureus infection (Figures 6C,D). We observed that the levels of melanin in the hemolymph of S. aureus-infected larvae were significantly increased when compared to PBS-treated group (approximately eightfolds after 1 and 3 h of infection; Figures 6C,D). The treatment with EbEO also significantly reduced the melanin content in hemolymph of G. mellonella larvae at both tested period (reductions of 42.19 and 55.41% after 1 and 3 h of infection, respectively; Figures 6C,D).

Discussion

Due the high chemical diversity exhibited by EOs, they have been pointed out as interesting source of lead molecules for development of alternative antimicrobial therapies (Rubini et al., 2018; Espinoza et al., 2019; Souza Dos Santos et al., 2019). These studies have encouraged the search of new EOs from unexploited plants, and one current example is E. brejoensis a plant recently described in Brazil (Mazine and Souza, 2008; Giaretta and Peixoto, 2014). Herein, we reported the activity of this oil against S. aureus, a pathogen highlighted due its ability to harbor genes related with virulence factors and drug resistance pathways (Kos et al., 2012; Berube and Bubeck Wardenburg, 2013; Vestergaard et al., 2019).

EbEO was able to inhibit the S. aureus strains with MIC50 of 256 μg/mL. As mentioned above, EbEO is mainly composed by sesquiterpenes such as δ-cadinene, β-caryophyllene, α-muurolol, α-cadinol, and bicyclogermacrene (Da Silva et al., 2015). The anti-S. aureus activity of EOs containing these sesquiterpenes is well documented in the literature (Mulyaningsih et al., 2010; Salleh et al., 2015; Guerrini et al., 2016; Nishanbaev et al., 2018; Salem et al., 2018). Our results from time-kill studies demonstrated that EbEO is an antibacterial agent showing a synergetic interaction with ampicillin, chloramphenicol, and kanamycin; and additive effects with ciprofloxacin and erythromycin. The improvement of antibiotic action has been reported for several EOs and isolated sesquiterpenes (Langeveld et al., 2014; Lahmar et al., 2017; Espinoza et al., 2019; Khoury et al., 2019).

The overuse and misuse of antibiotics has resulted in different gradient of drug concentrations in humans, animals, and environment (Andersson and Hughes, 2014; Huijbers et al., 2019). In this sense, bacteria are frequently exposed to Sub-MIC of the antimicrobial agent and these conditions could result in mutagenesis and release of microbial virulence factors (Andersson and Hughes, 2014; Jo and Ahn, 2016; Larsen et al., 2016; Huijbers et al., 2019). Thus, it is important to evaluate the effects of the antimicrobial agents in pathways related to mutagenesis and virulence (Hobdey et al., 2017; Duan et al., 2018). We first showed that EbEO did not induce the expression of recA which is the first gene in the SOS response. The activation of SOS response occurs when bacteria need to repair damages induced in the DNA due antibiotic treatment and other adverse conditions (Simmons et al., 2008; Silva et al., 2017). The activation of SOS pathway is associated with emergence of drug resistance and acquisition of virulence factors (Andreoni et al., 2019; Meunier et al., 2019).

Our data also report that EbEO interferes with the regulation of the accessory gene regulator (agr)-mediated quorum sensing. This system upregulates the production of secreted virulence factors (such as α-hemolysin encoded by hla) and downregulates cell surface proteins (such as protein A encoded by spa) (Gottschalk et al., 2013; Singh and Ray, 2014). We demonstrated that sub-inhibitory concentrations of EbEO decreased the expression of hla and increased the expression of spa. Further, S. aureus grown in the presence of EbEO displayed reduced hemolytic activity and less ability to survival in whole blood. α-Hemolysin induces toxicity toward a broad range of cells and is associated to severe injuries in cutaneous (skin necrosis) and systemic infections (Berube and Bubeck Wardenburg, 2013; Geoghegan et al., 2018; Surewaard et al., 2018).

Other antivirulence effect of EbEO is the inhibition of STX production, a carotenoid from S. aureus membrane that confers protection against reactive oxygen species produced by host defense, allowing the bacteria to persist in the inflammation site (Liu and Nizet, 2009; Pannu et al., 2019). These properties make STX an attractive target for antivirulence therapy as demonstrated for some plant-derived compounds (Lee et al., 2013; Silva et al., 2017; Colasso et al., 2019). The inhibitory effects of EbEO toward STX production could be confirmed by the fact that S. aureus grown in the presence of this oil showed increased susceptibility to hydrogen peroxide. In addition, it may also relate to the efficacy of EbEO to rescue C. elegans and G. mellonella from S. aureus infection.

Caenorhabditis elegans is free-living terrestrial nematode considered a fast, cheap, and efficient model for in vivo testing of antimicrobial substances since it is susceptible to human pathogens such as S. aureus (Kong et al., 2014, 2016a). Our results showed that the treatment with EbEO increased the worm lifespam and decreased the bacterial load. The anti-infective efficacy of EbEO was also demonstrated using G. mellonella larvae. EbEO-treated animals also showed lower levels of melanin, a soluble molecule part of the humoral response of G. mellonella (together with lysozyme, antimicrobial peptides, and opsonins) (Zdybicka-Barabas et al., 2013; Tsai et al., 2016). The melanogenesis is part of prophenoloxidase cascade which is activated by pathogens and other foreign particles leading accumulation of nodules in order to control the microbial replication (Trevijano-Contador and Zaragoza, 2018). The melanin overproduction results in high levels of cytotoxic compounds that may induce serious damage to host tissues and cells (Zdybicka-Barabas et al., 2014). In this sense, the oil could also protect the larvae against the deleterious effects related to S. aureus infection.

Taken together, the results indicated the EO of E. brejoensis is an important source of molecules with anti-S. aureus action, even against MDR strains. Importantly, the oil reduced the expression of significant factors involved in S. aureus virulence and impaired the ability of this bacterium to survive in adverse conditions such as whole blood and under oxidative stress. The antimicrobial efficacy was confirmed using two alternative models of infections based on C. elegans and G. mellonella. These data denote the importance of prospecting new species from underexploited environmental (such as Brazilian caatinga) in order to identify new lead molecules for antimicrobial therapy. Further testing is required to know the mode of action of EbEO and details about the action of this oil against the virulence of S. aureus as well as individual role of the main components of the EO of E. brejoensis are essential for antimicrobial action.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

Author Contributions

CB and LS contributed to conceptualization and investigation. AL-O, KK, MC, and MV contributed to resources. CB, LS, AL-O, and CS contributed to investigation and formal analysis. CB, LS, MV, MC, MS, and KK contributed to writing original draft. CB, MV, and LS contributed to supervision, writing-review, editing, and project administration.

Funding

This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (Proc.2017/06630-7); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (401452/2016-6).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Footnotes

  1. ^www.graphpad.com

References

Alves, J. C. O., Ferreira, G. F., Santos, J. R., Silva, L. C. N., Rodrigues, J. F. S., Neto, W. R. N., et al. (2017). Eugenol induces phenotypic alterations and increases the oxidative burst in Cryptococcus. Front. Microbiol. 8:2419. doi: 10.3389/fmicb.2017.02419

PubMed Abstract | CrossRef Full Text | Google Scholar

Andersson, D. I., and Hughes, D. (2014). Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12, 465–478. doi: 10.1038/nrmicro3270

PubMed Abstract | CrossRef Full Text | Google Scholar

Andreoni, F., Toyofuku, M., Menzi, C., Kalawong, R., Mairpady Shambat, S., Francois, P., et al. (2019). Antibiotics stimulate formation of vesicles in Staphylococcus aureus in both phage-dependent and -independent fashions and via different routes. Antimicrob. Agents Chemother. 63:e01439-18. doi: 10.1128/AAC.01439-18

PubMed Abstract | CrossRef Full Text | Google Scholar

Asgeirsson, H., Thalme, A., and Weiland, O. (2018). Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review. Infect Dis. 50, 175–192.

Google Scholar

Bakthavatchalam, Y. D., Veeraraghavan, B., Devanga Ragupathi, N. K., Babu, P., Munuswamy, E., and David, T. (2017). Draft genome sequence of reduced teicoplanin-susceptible and vancomycin-heteroresistant methicillin-resistant Staphylococcus aureus from sepsis cases. J. Glob. Antimicrob. Resist. 8, 169–171. doi: 10.1016/j.jgar.2016.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Berube, B. J., and Bubeck Wardenburg, J. (2013). Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins 5, 1140–1166. doi: 10.3390/toxins5061140

PubMed Abstract | CrossRef Full Text | Google Scholar

Capone, A., Cafiso, V., Campanile, F., Parisi, G., Mariani, B., Petrosillo, N., et al. (2016). In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Eur. J. Clin. Microbiol. Infect. Dis. 35, 625–631. doi: 10.1007/s10096-016-2581-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Colasso, A. H. M., Barros, T. F., Figueiredo, I., Carvalho Junior, A. R., Fernandes, E. S., Uchoa, M. R. B., et al. (2019). The latex of Euphorbia tirucalli inhibits staphyloxanthin production and protects Tenebrio molitor larvae against Staphylococcus aureus infection. Nat. Prod. Res. doi: 10.1080/14786419.2019.1582036 [Epub ahead of print].

CrossRef Full Text | PubMed Abstract | Google Scholar

Da Silva, A. G., Alves, R. C. C., Filho, C. M. B., Bezerra-Silva, P. C., Santos, L. M. M. D., Foglio, M. A., et al. (2015). Chemical composition and larvicidal activity of the essential oil from leaves of Eugenia brejoensis Mazine (Myrtaceae). J. Essent. Oil Bear. Plants 18, 1441–1447. doi: 10.1080/0972060x.2014.1000390

CrossRef Full Text | Google Scholar

Da Silva, A. P., Nascimento Da Silva, L. C., Martins Da Fonseca, C. S., De Araujo, J. M., Correia, M. T., Cavalcanti Mda, S., et al. (2016). Antimicrobial activity and phytochemical analysis of organic extracts from cleome spinosa Jaqc. Front. Microbiol. 7:963. doi: 10.3389/fmicb.2016.00963

PubMed Abstract | CrossRef Full Text | Google Scholar

De Carvalho, S. P., De Almeida, J. B., De Freitas, L. M., Guimaraes, A. M. S., Do Nascimento, N. C., Dos Santos, A. P., et al. (2019). Genomic profile of Brazilian methicillin-resistant Staphylococcus aureus resembles clones dispersed worldwide. J. Med. Microbiol. 68, 693–702. doi: 10.1099/jmm.0.000956

PubMed Abstract | CrossRef Full Text | Google Scholar

Dos Santos, B. S., Da Silva, L. C., Da Silva, T. D., Rodrigues, J. F., Grisotto, M. A., Correia, M. T., et al. (2016). Application of omics technologies for evaluation of antibacterial mechanisms of action of plant-derived products. Front. Microbiol. 7:1466.

PubMed Abstract | Google Scholar

Duan, J., Li, M., Hao, Z., Shen, X., Liu, L., Jin, Y., et al. (2018). Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS. Emerg. Microbes Infect. 7:136. doi: 10.1038/s41426-018-0142-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Endimiani, A., Blackford, M., Dasenbrook, E. C., Reed, M. D., Bajaksouszian, S., Hujer, A. M., et al. (2011). Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio. Antimicrob. Agents Chemother. 55, 1684–1692. doi: 10.1128/AAC.01308-10

PubMed Abstract | CrossRef Full Text | Google Scholar

Espinoza, J., Urzua, A., Sanhueza, L., Walter, M., Fincheira, P., Munoz, P., et al. (2019). Essential oil, extracts, and sesquiterpenes obtained from the heartwood of pilgerodendron uviferum act as potential inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Front. Microbiol. 10:337. doi: 10.3389/fmicb.2019.00337

PubMed Abstract | CrossRef Full Text | Google Scholar

Geoghegan, J. A., Irvine, A. D., and Foster, T. J. (2018). Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 26, 484–497. doi: 10.1016/j.tim.2017.11.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Giaretta, A., and Peixoto, A. L. (2014). New records of Eugenia brejoensis Mazine (Myrtaceae) and complementary description. Check List 10, 1176–1178. doi: 10.15560/10.5.1176

CrossRef Full Text | Google Scholar

Gottschalk, S., Ifrah, D., Lerche, S., Gottlieb, C. T., Cohn, M. T., Hiasa, H., et al. (2013). The antimicrobial lysine-peptoid hybrid LP5 inhibits DNA replication and induces the SOS response in Staphylococcus aureus. BMC Microbiol. 13:192. doi: 10.1186/1471-2180-13-192

PubMed Abstract | CrossRef Full Text | Google Scholar

Guerrini, A., Sacchetti, G., Grandini, A., Spagnoletti, A., Asanza, M., and Scalvenzi, L. (2016). Cytotoxic effect and TLC bioautography-guided approach to detect health properties of amazonian Hedyosmum sprucei essential oil. Evid. Based Complement. Alternat. Med. 2016:1638342. doi: 10.1155/2016/1638342

PubMed Abstract | CrossRef Full Text | Google Scholar

Hobdey, S. E., Katahira, E. J., Dockstader, P., Davidson, S. M., Bond, L., Bolz, D. D., et al. (2017). Subinhibitory dalbavancin attenuates exotoxin production from methicillin-sensitive and methicillin-resistant Staphylococcus aureus in vitro. Antimicrob. Agents Chemother. 61:e01090-17. doi: 10.1128/AAC.01090-17

PubMed Abstract | CrossRef Full Text | Google Scholar

Huijbers, P. M. C., Flach, C. F., and Larsson, D. G. J. (2019). A conceptual framework for the environmental surveillance of antibiotics and antibiotic resistance. Environ. Int. 130:104880. doi: 10.1016/j.envint.2019.05.074

PubMed Abstract | CrossRef Full Text | Google Scholar

Jakobsen, H., Bojer, M. S., Marinus, M. G., Xu, T., Struve, C., Krogfelt, K. A., et al. (2013). The alkaloid compound harmane increases the lifespan of Caenorhabditis elegans during bacterial infection, by modulating the nematode’s innate immune response. PLoS One 8:e60519. doi: 10.1371/journal.pone.0060519

PubMed Abstract | CrossRef Full Text | Google Scholar

Jo, A., and Ahn, J. (2016). Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin. BMC Microbiol. 16:170. doi: 10.1186/s12866-016-0791-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Kang, J., Liu, L., Wu, X., Sun, Y., and Liu, Z. (2018). Effect of thyme essential oil against Bacillus cereus planktonic growth and biofilm formation. Appl. Microbiol. Biotechnol. 102, 10209–10218. doi: 10.1007/s00253-018-9401-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Khoury, M., El Beyrouthy, M., Ouaini, N., Eparvier, V., and Stien, D. (2019). Hirtellina lobelii DC. essential oil, its constituents, its combination with antimicrobial drugs and its mode of action. Fitoterapia 133, 130–136. doi: 10.1016/j.fitote.2019.01.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Kim, Y. G., Lee, J. H., Gwon, G., Kim, S. I., Park, J. G., and Lee, J. (2016). Essential oils and eugenols inhibit biofilm formation and the virulence of Escherichia coli O157: H7. Sci. Rep. 6:36377. doi: 10.1038/srep36377

PubMed Abstract | CrossRef Full Text | Google Scholar

Kong, C., Eng, S. A., Lim, M. P., and Nathan, S. (2016a). Beyond traditional antimicrobials: a Caenorhabditis elegans model for discovery of novel anti-infectives. Front. Microbiol. 7:1956.

PubMed Abstract | Google Scholar

Kong, C., Neoh, H. M., and Nathan, S. (2016b). Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy. Toxins 8:E72. doi: 10.3390/toxins8030072

PubMed Abstract | CrossRef Full Text | Google Scholar

Kong, C., Yehye, W. A., Abd Rahman, N., Tan, M. W., and Nathan, S. (2014). Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model. BMC Complement. Altern. Med. 14:4. doi: 10.1186/1472-6882-14-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Kos, V. N., Desjardins, C. A., Griggs, A., Cerqueira, G., Van Tonder, A., Holden, M. T., et al. (2012). Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States. mBio 3:e112. doi: 10.1128/mBio.00112-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Lahmar, A., Bedoui, A., Mokdad-Bzeouich, I., Dhaouifi, Z., Kalboussi, Z., Cheraif, I., et al. (2017). Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics. Microb. Pathog. 106, 50–59. doi: 10.1016/j.micpath.2016.10.018

PubMed Abstract | CrossRef Full Text | Google Scholar

Langeveld, W. T., Veldhuizen, E. J., and Burt, S. A. (2014). Synergy between essential oil components and antibiotics: a review. Crit. Rev. Microbiol. 40, 76–94. doi: 10.3109/1040841X.2013.763219

PubMed Abstract | CrossRef Full Text | Google Scholar

Larsen, J., Clasen, J., Hansen, J. E., Paulander, W., Petersen, A., Larsen, A. R., et al. (2016). Copresence of tet(K) and tet(M) in livestock-associated methicillin-resistant Staphylococcus aureus clonal complex 398 is associated with increased fitness during exposure to sublethal concentrations of tetracycline. Antimicrob. Agents Chemother. 60, 4401–4403. doi: 10.1128/AAC.00426-16

PubMed Abstract | CrossRef Full Text | Google Scholar

Lee, J. H., Cho, H. S., Kim, Y., Kim, J. A., Banskota, S., Cho, M. H., et al. (2013). Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus. Appl. Microbiol. Biotechnol 97, 4543–4552. doi: 10.1007/s00253-012-4674-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Liang, Y., Tu, C., Tan, C., El-Sayed Ahmed, M. A. E., Dai, M., Xia, Y., et al. (2019). Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China. Infect. Drug Resist. 12, 447–459. doi: 10.2147/IDR.S192611

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., et al. (2005). Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202, 209–215. doi: 10.1084/jem.20050846

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, G. Y., and Nizet, V. (2009). Color me bad: microbial pigments as virulence factors. Trends Microbiol. 17, 406–413. doi: 10.1016/j.tim.2009.06.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Mazine, F. F., and Souza, V. C. (2008). A new species of Eugenia (Myrtaceae) from north-eastern Brazil. Bot. J. Linn. Soc. 158, 775–777. doi: 10.1111/j.1095-8339.2008.00921.x

CrossRef Full Text | Google Scholar

Mcneil, J. C., and Fritz, S. A. (2019). Prevention strategies for recurrent community-associated Staphylococcus aureus skin and soft tissue infections. Curr. Infect. Dis. Rep. 21:12. doi: 10.1007/s11908-019-0670-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Mendes, J., Martins, H., Otoni, C., Santana, N., Silva, R., Da Silva, A., et al. (2018). Chemical composition and antibacterial activity of Eugenia brejoensis essential oil nanoemulsions against Pseudomonas fluorescens. LWT 93, 659–664. doi: 10.1016/j.lwt.2018.04.015

CrossRef Full Text | Google Scholar

Meunier, A., Nerich, V., Fagnoni-Legat, C., Richard, M., Mazel, D., Adotevi, O., et al. (2019). Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs. J. Antimicrob. Chemother. 74, 1572–1577. doi: 10.1093/jac/dkz070

PubMed Abstract | CrossRef Full Text | Google Scholar

Mittal, R. P., Rana, A., and Jaitak, V. (2018). Essential oils: an impending substitute of synthetic antimicrobial agents to overcome antimicrobial resistance. Curr. Drug Targets 20, 605–624. doi: 10.2174/1389450119666181031122917

PubMed Abstract | CrossRef Full Text | Google Scholar

Mulyaningsih, S., Youns, M., El-Readi, M. Z., Ashour, M. L., Nibret, E., Sporer, F., et al. (2010). Biological activity of the essential oil of Kadsura longipedunculata (Schisandraceae) and its major components. J. Pharm. Pharmacol. 62, 1037–1044. doi: 10.1111/j.2042-7158.2010.01119.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Nielsen, A., Nielsen, K. F., Frees, D., Larsen, T. O., and Ingmer, H. (2010). Method for screening compounds that influence virulence gene expression in Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 509–512. doi: 10.1128/AAC.00940-09

PubMed Abstract | CrossRef Full Text | Google Scholar

Nishanbaev, S., Bobakulov, K., Okhundedaev, B., Sasmakov, S., Yusupova, E., Azimova, S., et al. (2018). Component composition of the extracts and essential oils from the Alhagi canescens, growing in Uzbekistan and their antimicrobial activity. Nat. Prod. Res. 33, 3417–3420. doi: 10.1080/14786419.2018.1475384

PubMed Abstract | CrossRef Full Text | Google Scholar

Oliveira De Souza, L. I., Bezzera-Silva, P. C., Do Amaral, Ferraz Navarro, D. M., Da Silva, A. G., and Dos Santos, et al. (2017). The chemical composition and trypanocidal activity of volatile oils from Brazilian caatinga plants. Biomed. Pharmacother. 96, 1055–1064. doi: 10.1016/j.biopha.2017.11.121

PubMed Abstract | CrossRef Full Text | Google Scholar

Pannu, M. K., Hudman, D. A., Sargentini, N. J., and Singh, V. K. (2019). Role of SigB and staphyloxanthin in radiation survival of Staphylococcus aureus. Curr. Microbiol. 76, 70–77. doi: 10.1007/s00284-018-1586-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Rao, J., Chen, B., and Mcclements, D. J. (2019). Improving the efficacy of essential oils as antimicrobials in foods: mechanisms of action. Annu. Rev. Food Sci. Technol. 10, 365–387. doi: 10.1146/annurev-food-032818-121727

PubMed Abstract | CrossRef Full Text | Google Scholar

Rubini, D., Banu, S. F., Nisha, P., Murugan, R., Thamotharan, S., Percino, M. J., et al. (2018). Essential oils from unexplored aromatic plants quench biofilm formation and virulence of Methicillin resistant Staphylococcus aureus. Microb. Pathog. 122, 162–173. doi: 10.1016/j.micpath.2018.06.028

PubMed Abstract | CrossRef Full Text | Google Scholar

Salem, M. Z. M., El-Hefny, M., Ali, H. M., Elansary, H. O., Nasser, R. A., El-Settawy, A. A. A., et al. (2018). Antibacterial activity of extracted bioactive molecules of Schinus terebinthifolius ripened fruits against some pathogenic bacteria. Microb. Pathog. 120, 119–127. doi: 10.1016/j.micpath.2018.04.040

PubMed Abstract | CrossRef Full Text | Google Scholar

Salleh, W. M., Ahmad, F., and Yen, K. H. (2015). Chemical compositions and biological activities of the essential oils of Beilschmiedia madang Blume (Lauraceae). Arch. Pharm. Res. 38, 485–493. doi: 10.1007/s12272-014-0460-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Silva, L. N., Da Hora, G. C. A., Soares, T. A., Bojer, M. S., Ingmer, H., Macedo, A. J., et al. (2017). Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors. Sci. Rep. 7:2823. doi: 10.1038/s41598-017-02712-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Simmons, L. A., Foti, J. J., Cohen, S. E., and Walker, G. C. (2008). The SOS regulatory network. EcoSal Plus 2008, 1–48. doi: 10.1128/ecosalplus.5.4.3

PubMed Abstract | CrossRef Full Text | Google Scholar

Singh, R., and Ray, P. (2014). Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microbiol. 9, 669–681. doi: 10.2217/fmb.14.31

PubMed Abstract | CrossRef Full Text | Google Scholar

Souza Dos Santos, B., Bezerra Filho, C. M., Alves Do Nascimento, J. A. Jr., Brust, F. R., Bezerra-Silva, P. C., Lino Da Rocha, S. K., et al. (2019). Anti-staphylococcal activity of Syagrus coronata essential oil: Biofilm eradication and in vivo action on Galleria mellonela infection model. Microb. Pathog. 131, 150–157. doi: 10.1016/j.micpath.2019.04.009

PubMed Abstract | CrossRef Full Text | Google Scholar

Stevanovic, Z. D., Bosnjak-Neumuller, J., Pajic-Lijakovic, I., Raj, J., and Vasiljevic, M. (2018). Essential oils as feed additives-future perspectives. Molecules 23:1717. doi: 10.3390/molecules23071717

PubMed Abstract | CrossRef Full Text | Google Scholar

Stiernagle, T. (2006). “Maintenance of C. elegans,” in WormBook, ed. The C. elegans Research Community (Pasadena, CA: WormBook).

Google Scholar

Surewaard, B. G. J., Thanabalasuriar, A., Zeng, Z., Tkaczyk, C., Cohen, T. S., Bardoel, B. W., et al. (2018). Alpha-Toxin induces platelet aggregation and liver injury during Staphylococcus aureus Sepsis. Cell Host Microbe 24:e273. doi: 10.1016/j.chom.2018.06.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Taghavi, T., Kim, C., and Rahemi, A. (2018). Role of natural volatiles and essential oils in extending shelf life and controlling postharvest microorganisms of small fruits. Microorganisms 6:104. doi: 10.3390/microorganisms6040104

PubMed Abstract | CrossRef Full Text | Google Scholar

Trevijano-Contador, N., and Zaragoza, O. (2018). Immune response of Galleria mellonella against human fungal pathogens. J. Fungi 5:E3.

Google Scholar

Tsai, C. J., Loh, J. M., and Proft, T. (2016). Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7, 214–229. doi: 10.1080/21505594.2015.1135289

PubMed Abstract | CrossRef Full Text | Google Scholar

Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., et al. (2019). Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat. Rev. Microbiol. 17, 203–218. doi: 10.1038/s41579-018-0147-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Vestergaard, M., Frees, D., and Ingmer, H. (2019). Antibiotic resistance and the MRSA problem. Microbiol. Spectr. 7:GPP3-0057-2018. doi: 10.1128/microbiolspec.GPP3-0057-2018

PubMed Abstract | CrossRef Full Text | Google Scholar

Vestergaard, M., Paulander, W., and Ingmer, H. (2015). Activation of the SOS response increases the frequency of small colony variants. BMC Res. Notes 8:749. doi: 10.1186/s13104-015-1735-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Werth, B. J., Barber, K. E., Ireland, C. E., and Rybak, M. J. (2014). Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations. Antimicrob. Agents Chemother. 58, 3177–3181. doi: 10.1128/AAC.00088-14

PubMed Abstract | CrossRef Full Text | Google Scholar

Zdybicka-Barabas, A., Mak, P., Jakubowicz, T., and Cytrynska, M. (2014). Lysozyme and defense peptides as suppressors of phenoloxidase activity in Galleria mellonella. Arch. Insect Biochem. Physiol. 87, 1–12. doi: 10.1002/arch.21175

PubMed Abstract | CrossRef Full Text | Google Scholar

Zdybicka-Barabas, A., Staczek, S., Mak, P., Skrzypiec, K., Mendyk, E., and Cytrynska, M. (2013). Synergistic action of Galleria mellonella apolipophorin III and lysozyme against Gram-negative bacteria. Biochim. Biophys. Acta 1828, 1449–1456. doi: 10.1016/j.bbamem.2013.02.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Caenorhabditis elegans, Galleria melonella, infections models, multidrug resistance, natural products, Staphylococcus aureus, virulence factors

Citation: Bezerra Filho CM, da Silva LCN, da Silva MV, Løbner-Olesen A, Struve C, Krogfelt KA, Correia MTS and Vilela Oliva ML (2020) Antimicrobial and Antivirulence Action of Eugenia brejoensis Essential Oil in vitro and in vivo Invertebrate Models. Front. Microbiol. 11:424. doi: 10.3389/fmicb.2020.00424

Received: 19 October 2019; Accepted: 27 February 2020;
Published: 19 March 2020.

Edited by:

Kin Weng Kong, University of Malaya, Malaysia

Reviewed by:

Jianhua Wang, Feed Research Institute (CAAS), China
Nayeli Alva-Murillo, University of Guanajuato, Mexico

Copyright © 2020 Bezerra Filho, da Silva, da Silva, Løbner-Olesen, Struve, Krogfelt, Correia and Vilela Oliva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Clovis Macêdo Bezerra Filho, clovisfilho@gmail.com; Luís Cláudio Nascimento da Silva, luisclaudionsilva@yahoo.com.br; Maria Luiza Vilela Oliva, mlvoliva@unifesp.br